Aleksandra (Kirovski) Petrovic MD

Pediatric Hematology & Oncology•Seattle, WA

Associate Professor, University of Washington

Join to View Full Profile

4800 Sand Point Way NESeattle, WA 98105
Phone+1 206-987-7450
Fax+1 206-987-3830

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2000 - 2003
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1997 - 2000
Oregon Health and Science University School of MedicineClass of 1997

Certifications & Licensure

WA State Medical License 2016 - 2027
AK State Medical License 2021 - 2026
ID State Medical License 2021 - 2023
MT State Medical License 2021 - 2023
FL State Medical License 2003 - 2021
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Stem Cell Related Donor Safety Study Start of enrollment: 2010 Jan 01
Completed
A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies Start of enrollment: 2009 Oct 01
Completed
Phase 2
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02
Enrolling by invitation
Patients Treated for SCID (1968-Present) Start of enrollment: 2011 May 15
Enrolling by invitation
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RECRUITING
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Completed
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
COMPLETED
PHASE3
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation Start of enrollment: 2012 Feb 01
Recruiting
Phase 2
Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 Start of enrollment: 2014 Feb 02
Completed
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 Start of enrollment: 2014 Jun 01
Enrolling by invitation
Join now to see all

Publications & Presentations

PubMed

The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.
Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert
Transplantation and Cellular Therapy. 2025-02-01
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.
Lev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, Kyle Hebert, Donna S Neuberg
Bone Marrow Transplantation. 2024-05-01
10 citations
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Jennifer W Leiding, Danielle E Arnold, Suhag Parikh, Brent Logan, Rebecca A Marsh
Blood. 2023-12-14

Press Mentions

Using Gene Therapy to Build an Immune System in Newborns Without OneAugust 29th, 2018